AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $103.20
- 52-wk high
- $131.24
- High
- $104.53
- 52-wk low
- $32.00
- Low
- $97.00
- Prev close
- $103.83
- Mkt cap
- $4.34B
- Volume
- 545.8K
- P/B
- 5.1x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -72.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings landed in line with what analysts expected.
Earnings per share
-$0.58 expected
What the street expects next
EPS expected
-$0.77 to -$0.51
Revenue expected
6 analysts
Last 30 days
Analysts raising estimates
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $0 |
| What it spent | ||||
| Research and development | $18.1M | $18.2M | $20.9M | $18.6M |
| Sales and admin | $2.3M | $4.8M | $8.9M | $10.9M |
| Total operating expenses | $20.3M | $23.0M | $29.9M | $29.6M |
| What was left | ||||
| Operating profit | -$20.3M | -$23.0M | -$29.9M | -$29.6M |
| Interest on debt | — | $532.0K | — | — |
| Profit before tax | -$20.1M | -$21.8M | -$27.2M | -$23.5M |
| Net profit | -$20.1M | -$21.8M | -$27.2M | -$23.5M |
| EBITDA | -$19.2M | -$21.3M | -$27.2M | -$29.6M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Seven Fleet Capital Management LP Purchases Shares of 80,000 Veradermics, Incorporated $MANE
Leans bullishSep 5Hollander David Receives 9,650 Shares and 19,300 Derivative Securities from Veradermics on September 1, 2026
Leans bullishSep 4Montanova Capital LLC Makes New Investment in Veradermics, Incorporated $MANE
Leans bullishSep 1Bamco Inc. NY Purchases 169,913 Shares of Veradermics, Incorporated $MANE
NeutralAug 27Veradermics, Incorporated (NYSE:MANE) Receives Consensus Rating of "Moderate Buy" from Analysts
Leans bullishAug 27
Macro
10 macro signals shaping MANE right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results